Clinical findings support the safety and efficacy of BMND08 at a maximum dosage of 12mg
This newly set up Centre for bio-analytical testing has already received European Regulatory Authority clearance recently
The product will be launched in March 2024
The National One Health Mission will help India to achieve integrated disease control and pandemic preparedness
Cipla completes transfer of Generics Business Undertaking
_256_384.jpg)
The overall transaction is expected to conclude over next 12-15 months subject to receipt of all relevant shareholder and regulatory approvals
The agreement licenses the company to launch in the United States, in February 2025, once approved by the U.S. FDA
The plant will drive pharmaceutical innovation in the Northeastern India
The objective of GCMC is well aligned to WHO’s call to action and India’s National Biotechnology Development Strategy
Patients visiting OPD sections of hospitals use their Ayushman Bharat Health Account (ABHA) to get instant tokens to save time spent in registration queues
Subscribe To Our Newsletter & Stay Updated
